Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse M Cedarbaum

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|December 28, 2023
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's DiseaseAnat Mirelman, Jana Volkov, Amit Salomon, et al.
Journal of Parkinson'S Disease|January 23, 2026
Analysis of α-synuclein seed amplification assay in carriers of <i>GBA1</i> and <i>LRRK2</i> pathogenic variantsKyle B Fraser, Anat Mirelman, Omar S Mabrouk, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Inflamed Microglia like Macrophages in the Central Nervous System of Prodromal Parkinson's DiseaseLe Zhang, Yoshiaki Yasumizu, M Elizabeth Deerhake, et al.
Neurobiology of Disease|November 2, 2018
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease modelsAndreas Weihofen, YuTing Liu, Joseph W Arndt, et al.
NPJ Parkinson'S Disease|January 3, 2025
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patientsAmgad Droby, Avital Yoffe-Vasiliev, Daniel Atias, et al.
Ophthalmology|August 25, 2009
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, David J Browning, et al.
Journal of Parkinson'S Disease|May 22, 2023
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn M Stebbins, et al.
Journal of Parkinson'S Disease|May 22, 2023
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn T Stebbins, et al.
Journal of Parkinson'S Disease|September 17, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Movement Disorders : Official Journal of the Movement Disorder Society|December 28, 2023
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's DiseaseAnat Mirelman, Jana Volkov, Amit Salomon, et al.
Journal of Parkinson'S Disease|January 23, 2026
Analysis of α-synuclein seed amplification assay in carriers of <i>GBA1</i> and <i>LRRK2</i> pathogenic variantsKyle B Fraser, Anat Mirelman, Omar S Mabrouk, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Inflamed Microglia like Macrophages in the Central Nervous System of Prodromal Parkinson's DiseaseLe Zhang, Yoshiaki Yasumizu, M Elizabeth Deerhake, et al.
Neurobiology of Disease|November 2, 2018
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease modelsAndreas Weihofen, YuTing Liu, Joseph W Arndt, et al.
NPJ Parkinson'S Disease|January 3, 2025
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patientsAmgad Droby, Avital Yoffe-Vasiliev, Daniel Atias, et al.
Ophthalmology|August 25, 2009
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, David J Browning, et al.
Journal of Parkinson'S Disease|May 22, 2023
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn M Stebbins, et al.
Journal of Parkinson'S Disease|May 22, 2023
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn T Stebbins, et al.
Journal of Parkinson'S Disease|September 17, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Pageof 8